Safety and Efficacy Study of Erythropoietin as add-on Therapy of Methylprednisolone to Treat Acute Optic Neuritis

NCT00355095 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Optic Neuritis

Interventions

DRUG: Erythropoietin

Sponsor

Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH